Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. Cancer J Clin. 2015;65:87.
   PubMed Web of Science ®Google Scholar
• Insa A, Lluch A, Prosper F, et al. Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat. 1999;56:67–78.
   PubMed Web of Science ®Google Scholar
• Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106:1624.
   PubMed Web of Science ®Google Scholar
• Gradishar WJ, Anderson BO, Balassanian R, et al. NCCN guidelines insights: breast cancer, Version 1.2017. J Natl Compr Cancer Netw. 2017;15:433.
   PubMed Web of Science ®Google Scholar
• Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644.
   PubMed Web of Science ®Google Scholar
• Belda T, Montalvá EM, Lópezandújar R, et al. Role of resection surgery in breast cancer liver metastases: experience over the last 10 years in a reference hospital. Cirugía Española. 2010;88:167–173.
   PubMed Web of Science ®Google Scholar
• Ma R, Feng Y, Lin S, et al. Mechanisms involved in breast cancer liver metastasis. J Transl Med. 2015;13:64.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ahmed M, Cova L, et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265:958.
   PubMed Web of Science ®Google Scholar
• Jin K, Gao W, Lu Y, et al. Mechanisms regulating colorectal cancer cell metastasis into liver (Review). Oncol Lett. 2012;3:11–15.
   PubMed Web of Science ®Google Scholar
• Jakobs TF, Hoffmann RT, Schrader A, et al. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc Intervent Radiol. 2009;32:38–46.
   PubMed Web of Science ®Google Scholar
• Sofocleous CT, Nascimento RG, Gonen M, et al. Radiofrequency ablation in the management of liver Metastases from breast cancer. AJR Am J Roentgenol. 2007;189:883.
   PubMed Web of Science ®Google Scholar
• Meloni MF, Andreano A, Laeseke PF, et al. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation-intermediate and long-term survival rates. Radiology. 2009;253:861–869.
   PubMed Web of Science ®Google Scholar
• Bergenfeldt M, Jensen BV, Skjoldbye B, et al. Liver resection and local ablation of breast cancer liver metastases – A systematic review. Eur J Surg Oncol. 2011;37:549–557.
   PubMed Web of Science ®Google Scholar
• Lawes D, Chopada A, Gillams A, et al. Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer. Ann R Coll Surg Engl. 2006;88:639.
   PubMed Web of Science ®Google Scholar
• Kitagawa D, Horiguchi S, Yamashita T, et al. Comparison of outcomes between women with de novo stage IV and relapsed breast cancer. J Nippon Med Sch. 2014;81:139–147.
   PubMed Web of Science ®Google Scholar
• Khanfir A, Lahiani F, Bouzguenda R, et al. Prognostic factors and survival in metastatic breast cancer: a single institution experience. Rep Pract Oncol Radiother. 2013;18:127–132.
   PubMedGoogle Scholar
• Chen MH, Yang W, Yan K, et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients-mathematic model, overlapping mode, and electrode placement process. Radiology. 2004;232:260.
   PubMed Web of Science ®Google Scholar
• Chen MH, Yang W, Yan K, et al. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol. 2006;17:671–683.
   PubMed Web of Science ®Google Scholar
• Yan K, Yang W, Chen MH, et al. Clinical application of hepatic wedge ablation for treating liver malignancies of the inferior margin: a new ablation technique. Int J Hyperthermia. 2017;33:203–211.
   PubMed Web of Science ®Google Scholar
• Chen MH, Yang W, Yan K, et al. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach. Abdom Imaging. 2008;33:428–436.
   PubMed Web of Science ®Google Scholar
• Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34: 11–29.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology. 2014;273:241–260.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36:166–175.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyashiro I, Ito H, et al. Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci. 2014;105:1480–1486.
   PubMed Web of Science ®Google Scholar
• Cowppli-Bony A, Uhry Z, Remontet L, et al. Survival of solid cancer patients in France, 1989–2013: a population-based study. Eur J Cancer Prev. 2017;26:461–468.
   PubMed Web of Science ®Google Scholar
• Kamby C, Dirksen H, Vejborg I, et al. Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer. Cancer. 1987;59:1524–1529.
   PubMed Web of Science ®Google Scholar
• Bacalbaşa N, Balescu I, Dima S, et al. Long-term survivors after liver resection for breast cancer liver metastases. Anticancer Res. 2015;35:6919–6923.
   PubMed Web of Science ®Google Scholar
• Rubino A, Doci R, Foteuh JC, et al. Hepatic metastases from breast cancer. Updates Surg. 2010;62:143–148.
   PubMedGoogle Scholar
• Ward EM, Desantis CE, Lin CC, et al. Cancer statistics: breast cancer in situ. Cancer J Clin. 2015;65:481–495.
   PubMed Web of Science ®Google Scholar
• Bacalbasa N, Dima SO, Purtanpurnichescu R, et al. Role of surgical treatment in breast cancer liver metastases: a single center experience. Anticancer Res. 2014;34:5563.
   PubMed Web of Science ®Google Scholar
• Abbott DE, Brouquet A, Mittendorf EA, et al. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery. 2012;151:710–716.
   PubMed Web of Science ®Google Scholar
• Sadot E, Lee SY, Sofocleous CT, et al. Hepatic resection or ablation for isolated breast cancer liver metastasis: a case-control study with comparison to medically treated patients. Ann Surg. 2016;264:147.
   PubMed Web of Science ®Google Scholar
• Spolverato G, Vitale A, Bagante F, et al. Liver resection for breast cancer liver metastases: a cost-utility analysis. Ann Surg. 2017;265:792.
   PubMed Web of Science ®Google Scholar
• Illing R, Gillams A. Radiofrequency ablation in the treatment of breast cancer liver metastases. Clin Oncol. 2010;22:781–784.
   Web of Science ®Google Scholar
• Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818.
   PubMed Web of Science ®Google Scholar
• Liu M, Huang G, Xu M, et al. Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacy. Int J Hyperthermia. 2017;33:446– 433.
   PubMed Web of Science ®Google Scholar
• Gunabushanam G, Sharma S, Thulkar S, et al. Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients. J Vasc Interv Radiol. 2007;18:67–72.
   PubMed Web of Science ®Google Scholar
• Veltri A, Gazzera C, Barrera M, et al. Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease. Radiol Med. 2014;119:327–333.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Do KG, et al. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29:268–275.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu XL, Liang P, et al. Microwave ablation is effective against liver metastases from gastric adenocarcinoma. Int J Hyperthermia. 2017;33:1–23.
   PubMed Web of Science ®Google Scholar
• Tabaries S, Dong Z, Annis MG, et al. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene. 2011;30:1318–1328.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Gonen M, et al. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes—a 10-year experience at a single center. Radiology. 2016;278:601–611.
   PubMed Web of Science ®Google Scholar
• Duan XF, Dong NN, Zhang T, et al. The prognostic analysis of clinical breast cancer subtypes among;patients with liver metastases from breast cancer. Int J Clin Oncol. 2013;18:26.
   PubMed Web of Science ®Google Scholar
• Caralt M, Bilbao I, Cortés J, et al. Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer. Ann Surg Oncol. 2008;15:2804.
   PubMed Web of Science ®Google Scholar
• Selzner M, Morse MA, Vredenburgh JJ, et al. Liver metastases from breast cancer: long-term survival after curative resection. Surgery. 2000;127:383–389.
   PubMed Web of Science ®Google Scholar